Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis
NCT05802264
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
108
Enrollment
INDUSTRY
Sponsor class
Conditions
Cystic Fibrosis
Interventions
COMBINATION_PRODUCT:
ABCI
COMBINATION_PRODUCT:
Placebo
Sponsor
Cystetic Medicines, Inc.
Collaborators
[object Object]